The Certara Market Access Channel podcast

(3) The Part B IPI Model

0:00
26:06
Recuar 15 segundos
Avançar 15 segundos
In this episode, we're dissecting the US Administrations initiative to overhaul Medicare Part B drug reimbursement, incorporating international reference pricing. Experts on call Ulrich Neumann, Sr. Director, US Access [email protected] Additional notes: - We referenced the Implications of Pricing on Innovation which is thoroughly discussed in this article by USC's Darius Lakdawalla Lakdawalla, Darius N. 2018. "Economics of the Pharmaceutical Industry." Journal of Economic Literature, 56 (2): 397-449. DOI: 10.1257/jel.20161327

Mais episódios de "The Certara Market Access Channel"